[PALLIATIVE GENERAL AND LOCAL TREATMENT OF MALIGNANT TUMORS WITH TRENIMON].
D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D001984:Bronchial Neoplasms; D003110:Colonic Neoplasms; D003520:Cyclophosphamide; D006801:Humans; D008228:Lymphoma, Non-Hodgkin; D009369:Neoplasms / Q000532:radiotherapy* / Q000628:therapy*; D012516:Osteosarcoma; D010166:Palliative Care; D010190:Pancreatic Neoplasms; D012509:Sarcoma; D013274:Stomach Neoplasms; D014228:Triaziquone
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D014228:Triaziquone
ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BRONCHIAL NEOPLASMS; COLONIC NEOPLASMS; CYCLOPHOSPHAMIDE; LYMPHOSARCOMA; NEOPLASM RADIOTHERAPY; NEOPLASM THERAPY; PALLIATIVE TREATMENT; PANCREATIC NEOPLASMS; SARCOMA, OSTEOGENIC; STOMACH NEOPLASMS; TRIAZIQUONE
PALLIATIVE ALLGEMEIN- UND LOKALBEHANDLUNG MALIGNER GESCHWUELSTE MIT TRENIMON.